Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/10/2010US20100144814 Novel 4-phenylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof
06/10/2010US20100144813 Novel 4-heteroarylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof
06/10/2010US20100144812 Heterocyclic Sulfonamide Inhibitors of Beta Amyloid Production Containing an Azole
06/10/2010US20100144811 Combination
06/10/2010US20100144810 Angiotensin ii receptor antagonists
06/10/2010US20100144809 Novel benzamidine derivatives useful as potassium channel modulators
06/10/2010US20100144807 Pharmaceutical composition for modified release
06/10/2010US20100144806 Cyclopropanecarboxylic Acid Compound
06/10/2010US20100144805 Regulation of protein synthesis
06/10/2010US20100144804 Polymorph of a Pharmaceutical
06/10/2010US20100144802 Small Molecule Inhibitors for Immune Modulation
06/10/2010US20100144801 Muscarinic receptor antagonists
06/10/2010US20100144800 extended release tablet formulation of niacin
06/10/2010US20100144799 Optical enantiomers of phenyramidol and process for chiral synthesis
06/10/2010US20100144798 Modulators of ATP-Binding Cassette Transporters
06/10/2010US20100144796 New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino- methyl)-phenylamino]-methyl-1-methyl-1h-benzimidazole-5-carbonyl) -pyridin-2-yl-amino]-propionate
06/10/2010US20100144795 Treatment of attention-deficit/hyperactivity disorder
06/10/2010US20100144793 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
06/10/2010US20100144792 Neurite formation promoter
06/10/2010US20100144791 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
06/10/2010US20100144790 Use of Thalidomide for Alzheimers Disease Treatment and Prevention
06/10/2010US20100144789 1-Isopropyl-2-Oxo-1,2-dihydropyridine-3-carboxamide Derivatives having 5-HT4 Receptor Agonistic Activity
06/10/2010US20100144788 4- [2- (4-methylphenylsulfanyd-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression
06/10/2010US20100144787 Quinolines and Their Therapeutic Use
06/10/2010US20100144786 Quinoline derivatives as crth2 receptor ligands
06/10/2010US20100144784 Aerosol formulation
06/10/2010US20100144783 Kinase inhibitors with improved cyp safety profile
06/10/2010US20100144782 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
06/10/2010US20100144781 Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene
06/10/2010US20100144780 salts of N-acridonacetic acid such as N-(1-deoxy-D-glucitol-1-yl)-N-ethyl ammonium 9-oxoacridine-10-ylacetate, having immunomodulating, antiparasitic, antisclerotic, antiviral, antibacterial, antifungal, antiphlogistic, antitumor, radioprotective and stressprotective activities
06/10/2010US20100144779 Marine Alkalod Makaluvamines and Derivatives Thereof
06/10/2010US20100144778 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
06/10/2010US20100144777 Method of Network-Based Identification of Multicomponent Synergy and Compositions for Use as Effective Component of Anti-Angiogenesis Medicines
06/10/2010US20100144776 Use of snps for the diagnosis of a pain protective haplotype in the gtp cyclohydrolase 1 gene (gch1)
06/10/2010US20100144775 Heterocyclic Cyclopamine Analogs and Methods of Use Thereof
06/10/2010US20100144774 Heterocyclic spiro-compounds
06/10/2010US20100144773 Pharmaceutical compositions for intranasal administration comprising choline salts of succinic acid
06/10/2010US20100144772 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
06/10/2010US20100144771 Novel Hydantoin Derivatives for the Treatment of Obstructive Airway Diseases
06/10/2010US20100144770 Pyrimidinones as Casein Kinase II (CK2) Modulators
06/10/2010US20100144769 Composition and method for improved bioavailability and enhanced brain delivery of 5 5-diphenyl barbituric acid
06/10/2010US20100144768 Kinase inhibitor compounds
06/10/2010US20100144767 Use of sodium channel blockers for the treatment of visceral pain or pain caused by cancer treatment
06/10/2010US20100144766 Composition and method for treating or preventing skeletal muscle fibrosis
06/10/2010US20100144765 5,6-trimethylenepyrimidin-4-one compounds
06/10/2010US20100144764 Pyrimidinedione derivatives and methods of use thereof
06/10/2010US20100144763 Pharmaceutical composition for inhibiting topoisomerase I and method for exploiting drug
06/10/2010US20100144762 Novel sulfonamides as l-cpt1 inhibitors
06/10/2010US20100144761 Antimicrobial Molecules For Treating Multi-Drug Resistant And Extensively Drug Resistant Strains Of Mycobacterium
06/10/2010US20100144760 Novel compounds
06/10/2010US20100144759 Novel n-(fluoro-pyrazinyl)-phenylsulfonamides as modulators of chemokine receptor ccr4
06/10/2010US20100144758 Azaindole p2x3 and p2x2/3 modulators
06/10/2010US20100144757 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
06/10/2010US20100144756 Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
06/10/2010US20100144755 Novel Compounds
06/10/2010US20100144754 Methods and Compositions for Treating or Preventing Narcotic Withdrawal Symptoms
06/10/2010US20100144753 Crystal modifications of transmission dyes
06/10/2010US20100144752 Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes
06/10/2010US20100144751 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS
06/10/2010US20100144750 Use of N-Phenyl-2-Pyrimidineamine Derivatives Against Mast Cell-Based Diseases Like Allergic Disorders
06/10/2010US20100144749 Treatment of cancers with acquired resistance to kit inhibitors
06/10/2010US20100144748 Methods involving aldose reductase inhibitors
06/10/2010US20100144747 1h-quinaz0line-2,4-diones
06/10/2010US20100144746 Method for restructuring a biological tissue comprising collagen fibrils and relative uses
06/10/2010US20100144745 Pyrrolopyrazinyl Urea Kinase Inhibitors
06/10/2010US20100144744 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
06/10/2010US20100144743 Compositions and methods for inhibition of tyrosine kinases
06/10/2010US20100144742 Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
06/10/2010US20100144741 Ethanolamine derivatives useful as bace inhibitors
06/10/2010US20100144740 Synergistic combinations of vr-1 antagonists and cox-2 inhibitors
06/10/2010US20100144739 Heterocyclic inhibitors of c-met and uses thereof
06/10/2010US20100144738 Inhibitors of c-met and uses thereof
06/10/2010US20100144737 Methods for inhibiting t helper cell differentiation
06/10/2010US20100144736 Novel biphenyl thio-urea derivatives useful as potassium channel modulators
06/10/2010US20100144735 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
06/10/2010US20100144734 1, 2, 3-Triazole derivatives as new cannabinoid-1 receptor antagonists
06/10/2010US20100144733 Compounds, compositions and methods comprising heteroaromatic derivatives
06/10/2010US20100144732 Pyrimidine kinase inhibitors
06/10/2010US20100144731 Novel Biccyclic Compounds As GATA Modulators
06/10/2010US20100144730 Pyridinonyl pdk1 inhibitors
06/10/2010US20100144729 Coumarin derivatives
06/10/2010US20100144728 Oxazolidinone For The Treatment And Prophylaxis Of Pulmonary Hypertension
06/10/2010US20100144727 Oxazolidine and Morpholine Carboxamide Derivatives as P2X7 Modulators
06/10/2010US20100144726 Novel indolic derivatives, their preparation processes and their uses in particular as antibacterials
06/10/2010US20100144724 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
06/10/2010US20100144723 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione
06/10/2010US20100144722 Novel heterocyclic compounds as gata modulators
06/10/2010US20100144721 Inhibitors of c-met and uses thereof
06/10/2010US20100144720 Inhibitors of human tumor-expressed ccxckr2
06/10/2010US20100144719 Pharmaceutical suspension
06/10/2010US20100144718 Treatment of diseases modulated by a h4 receptor agonist
06/10/2010US20100144717 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
06/10/2010US20100144716 New CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
06/10/2010US20100144715 Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel Blockers
06/10/2010US20100144714 Derivatives of imidazo pyrimido and diazepine pyrimidine-dione, and use thereof as a drug
06/10/2010US20100144713 6-and 7-amino isoquinoline compounds and methods for making and using the same
06/10/2010US20100144712 Triazole derivatives having antifungal activity, method for the preparation thereof, and pharmaceutical composition comprising the same
06/10/2010US20100144711 Pharmaceutical composition for oral administration
06/10/2010US20100144710 Piperazine and Piperidine MGLUR5 Potentiators
06/10/2010US20100144709 Thiadiazole derivatives for the treatment of neuro-degenerative diseases
1 ... 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 ... 7860